TianDuo Wang on Muck Rack

TianDuo Wang

As seen in: Nature, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with TianDuo

Contact TianDuo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

TinyLlama: An Open-Source Small Language Model

|
By Peiyuan Zhang, TianDuo Wang, Wei Lu, Guangtao Zeng
| huggingface.co
We present TinyLlama, a compact 1.1B language model pretrained on around 1 trillion tokens for approximately 3 epochs. Building on the architecture and tokenizer of Llama 2, TinyLlama leverages various advances contributed by the open-source community (e.g., FlashAttention), achieving better computational efficiency. Despite its relatively small size, TinyLlama demonstrates remarkable performance in a series of downstream tasks.
Open in Who Shared Issue with article?

TinyLlama: An Open-Source Small Language Model

|
By Guangtao Zeng, TianDuo Wang, Wei Lu
| arxiv.org
arXiv:2401.02385 (cs) Download PDF HTML (experimental) Comments: Subjects: Computation and Language (cs.CL); Artificial Intelligence (cs.AI) Cite as: arXiv:2401.02385 [cs.CL] (or arXiv:2401.02385v1 [cs.CL] for this version) https://doi.org/10.48550/arXiv.2401.02385 Submission history From: Guangtao Zeng [ view email] [v1] Thu, 4 Jan 2024 17:54:59 UTC (1,783 KB) Bibliographic Tools Bibliographic Explorer Toggle Bibliographic Explorer () Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle...
Open in Who Shared View Duplicates (692) Issue with article?

A synthetic Notch (synNotch) system linking intratumoral immune-cancer cell communication to a synthetic blood biomarker assay

|
By TianDuo Wang, John A. Ronald, YangHao Fu
| biorxiv.org
Abstract Introduction: Cellular immunotherapy has greatly improved cancer treatment in recent years. For instance, chimeric antigen receptor (CAR) T-cell therapy has been proven highly effective in treating hematological malignancies, and many CAR cell designs are being explored for solid tumors. However, many questions remain why responses differ across patients and some tumor types are resistant. Improved and relatively inexpensive ways to monitor these cells could provide some answers.
Open in Who Shared Issue with article?
See all 5 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with TianDuo

Contact TianDuo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified